Nektar Therapeutics | Azione

Prezzo Delle Azioni
68.84
Cambio Giornaliero
0.48 0.70%
Mensile
82.89%
Annuale
443.89%
Q1 Previsione
66.87




Azione Cambiamento Data
Agios Pharmaceuticals USD 32.92M 886K 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Amgen USD 6.22B 121M 2025-12
Baxter International USD 2.23B 228M 2025-12
BioCryst Pharmaceuticals USD 5.23M 188K 2025-09
Biogen USD 2.17B 41.3M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Cara Therapeutics USD 900K 0 2025-03
Cipla INR 61.6B 5.18B 2025-09
Dr.Reddys Laboratories INR 79.01B 3.19B 2025-12
Eisai JPY 236.46B 9.14B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Exelixis USD 27.4M 3.92M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Grifols EUR 3.56B 63.19M 2024-12
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Incyte USD 101.06M 17.61M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Karyopharm Therapeutics USD 3.97M 1.03M 2025-09
MacroGenics USD 8.75M 530K 2025-09
Merck USD 6.44B 157M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Takeda JPY 1.41T 107.71B 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12


Nektar Therapeutics Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.